Yelin Lapidot Holdings Management Ltd. Arvinas, Inc. Transaction History
Yelin Lapidot Holdings Management Ltd.
- $607 Billion
- Q3 2024
A detailed history of Yelin Lapidot Holdings Management Ltd. transactions in Arvinas, Inc. stock. As of the latest transaction made, Yelin Lapidot Holdings Management Ltd. holds 49,503 shares of ARVN stock, worth $1.3 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
49,503
Previous 49,503
-0.0%
Holding current value
$1.3 Million
Previous $1.32 Billion
7.48%
% of portfolio
0.2%
Previous 0.23%
Shares
1 transactions
Others Institutions Holding ARVN
# of Institutions
225Shares Held
69.3MCall Options Held
166KPut Options Held
131K-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$177 Million6.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.67MShares$176 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$165 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.99MShares$105 Million0.01% of portfolio
-
Avidity Partners Management LP Dallas, TX2.99MShares$78.6 Million3.91% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.4B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...